Unexpectedly, Immunotherapy Response Linked to Low TMB in rGMB Unexpectedly, Immunotherapy Response Linked to Low TMB in rGMB

In contrast to what has been seen in other tumor types, recurrent glioblastoma (rGMB) appears to respond better to immunotherapy when tumor mutational burden (TMB) is low.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news